Streetbeat News

Assets

FTRE

Fortrea Holdings reported disappointing Q4 financial results, leading to a decline in its share price. The company also announced plans to divest assets related to its Enabling Services segment.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:47 am

COIN

HOOD

QQQ

SPY

U.S. stocks are poised for a lower open as investors await the February CPI report, crucial for the Fed's rate decision. Last week, major indices closed lower, with tech stocks leading the decline. Analysts remain optimistic about the 'Magnificent 7' stocks despite recent volatility. SPDR S&P 500 ETF Trust and Invesco QQQ ETF saw premarket declines. Coinbase and Robinhood surged with Bitcoin's rise. Asana, Casey's General Stores, Oracle, and Vail Resorts are set to report earnings. Global markets showed mixed reactions, with Asian markets mostly down and European markets opening lower.

Portfolio Pulse from Shanthi Rexaline

March 11, 2024 | 11:24 am

CLDI

Calidi Biotherapeutics and City of Hope have received a $5.3M grant from the California Institute for Regenerative Medicine to advance their CLD-101 (Neuronova) treatment for ovarian cancer. This funding aims to support the development and potential commercialization of CLD-101, a promising therapeutic option for ovarian cancer patients.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:18 am

TSLA

Tesla's Gruenheide Gigafactory in Germany is currently disconnected from the grid, awaiting reconnection which could occur this evening. The restart of systems will be gradual, and the timeline for resuming full production is uncertain.

Portfolio Pulse from Charles Gross

March 11, 2024 | 11:15 am

LEGN

Legend Biotech announced that its cash, cash equivalents, deposits, and short-term investments totaling $1.3 billion as of December 31, 2023, are expected to sustain the company financially through the end of 2025.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:07 am

GDS

GDS Holdings Limited's shares surged 18.6% in premarket trading following reports that Hillhouse and Boyu are in discussions to invest in the company's Southeast Asia data centers. This development indicates a significant interest in GDS's expansion and operations in the region.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:04 am

EXK

Endeavour Silver reported its Q4 production results, with silver production at 1,406,423 ounces and gold production at 9,608 ounces. The company's performance in silver and gold production is a key indicator of its operational success.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 10:55 am

BTCUSD

ETHUSD

Bitcoin (BTC) surged past $70,000, setting a new all-time high, while Ethereum (ETH) crossed the $4,000 mark. Factors contributing to the surge include the London Stock Exchange's acceptance of Bitcoin and Ether ETNs, increased institutional investor interest, and the U.S. SEC's approval of spot Bitcoin-based ETFs. Tom Lee predicts a 119% increase in Bitcoin's price over the next 12-18 months.

Portfolio Pulse from Ramakrishnan M

March 11, 2024 | 10:54 am

FTRE

Fortrea is divesting its Endpoint Clinical and Fortrea Patient Access businesses to Arsenal Capital Partners to focus on clinical development phases 1 through 4. The deal aims to accelerate technology and enhance operations, with closing targeted for Q2 2024. Terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 10:32 am

BTCUSD

Robert Kiyosaki, author of 'Rich Dad Poor Dad,' has expressed concern over the rising U.S. debt, now at $34 trillion, increasing by $1 trillion every 90 days. He advocates for investing in gold, silver, and Bitcoin (BTC) as a response. Kiyosaki's bullish stance on Bitcoin remains, despite its recent volatility, predicting it could reach $300,000 in 2024. The U.S. debt situation has led to Moody's downgrading its outlook to negative, though the Aaa rating is maintained. Bitcoin recently hit a new all-time high of $69,170.63 but faced a dip due to market volatility.

Portfolio Pulse from Benzinga Neuro

March 11, 2024 | 10:30 am